Organic compounds -- part of the class 532-570 series – Organic compounds – Rare earth containing
Reexamination Certificate
2006-08-22
2006-08-22
Jones, Dameron L. (Department: 1618)
Organic compounds -- part of the class 532-570 series
Organic compounds
Rare earth containing
C424S001110, C424S001650, C424S009100
Reexamination Certificate
active
07094885
ABSTRACT:
The present invention relates to a method of suppressing bone marrow (BM) and treating conditions that arise in or near bone such as cancer, myeloproliferative diseases, autoimmune diseases, infectious diseases, metabolic diseases or genetic diseases, with compositions having as their active ingredient a radionuclide complexed with a chelating agent such as macrocyclic aminophosphonic acid.
REFERENCES:
patent: 3032584 (1962-05-01), Bergel et al.
patent: 3032585 (1962-05-01), Bergel et al.
patent: 3398198 (1968-08-01), Kersnar et al.
patent: 3726912 (1973-04-01), McCrary et al.
patent: 3852414 (1974-12-01), Adler et al.
patent: 3931396 (1976-01-01), Bardy et al.
patent: 3965254 (1976-06-01), Tofe et al.
patent: 3974268 (1976-08-01), Subramanian et al.
patent: 3989730 (1976-11-01), Subramanian et al.
patent: 4017596 (1977-04-01), Loberg et al.
patent: 4058704 (1977-11-01), Shimizu
patent: 4075314 (1978-02-01), Wolfangel et al.
patent: 4104366 (1978-08-01), Schmidt-Dunker et al.
patent: 4187284 (1980-02-01), Rolleston et al.
patent: 4399817 (1983-08-01), Benedict
patent: 4508625 (1985-04-01), Graham
patent: 4515767 (1985-05-01), Simon et al.
patent: 4560548 (1985-12-01), Simon et al.
patent: 4606907 (1986-08-01), Simon et al.
patent: 4639365 (1987-01-01), Sherry
patent: 4647447 (1987-03-01), Gries et al.
patent: 4678667 (1987-07-01), Meares et al.
patent: 4707353 (1987-11-01), Bugaj et al.
patent: 4752464 (1988-06-01), Lieberman et al.
patent: 4808541 (1989-02-01), Mikola et al.
patent: 4853209 (1989-08-01), Kaplan et al.
patent: 4882142 (1989-11-01), Simon et al.
patent: 4885363 (1989-12-01), Tweedle et al.
patent: 4897254 (1990-01-01), Simon et al.
patent: 4897255 (1990-01-01), Fritzberg et al.
patent: 4898724 (1990-02-01), Simon et al.
patent: 4937333 (1990-06-01), Garlich et al.
patent: 4957939 (1990-09-01), Gries et al.
patent: 4976950 (1990-12-01), Simon et al.
patent: 5059412 (1991-10-01), Simon et al.
patent: 5064633 (1991-11-01), Simon et al.
patent: 5066478 (1991-11-01), Simon et al.
patent: 5089249 (1992-02-01), Fritzberg et al.
patent: 5202109 (1993-04-01), Fritzberg et al.
patent: 5286497 (1994-02-01), Hendrickson et al.
patent: 5300279 (1994-04-01), Simon et al.
patent: 5393512 (1995-02-01), Vanderheyden et al.
patent: 5587451 (1996-12-01), Athey et al.
patent: 5621001 (1997-04-01), Canetta et al.
patent: 5641803 (1997-06-01), Canetta et al.
patent: 5665761 (1997-09-01), Canetta et al.
patent: 5670537 (1997-09-01), Canetta et al.
patent: 5679318 (1997-10-01), Vanderheyden et al.
patent: 5707610 (1998-01-01), Ibsen et al.
patent: 5708169 (1998-01-01), Hester, Jr. et al.
patent: 5712275 (1998-01-01), Van Gestel
patent: 5714467 (1998-02-01), Boman et al.
patent: 5714504 (1998-02-01), Lindberg et al.
patent: 5714604 (1998-02-01), Kiefer
patent: 5756472 (1998-05-01), Liesch et al.
patent: 5756505 (1998-05-01), Nishino et al.
patent: 5756685 (1998-05-01), Fritzberg et al.
patent: 5756725 (1998-05-01), Wilkening et al.
patent: 5760063 (1998-06-01), Lam et al.
patent: 5762907 (1998-06-01), Simon et al.
patent: 5770617 (1998-06-01), LaVoie et al.
patent: 5773421 (1998-06-01), Alder et al.
patent: 5773443 (1998-06-01), Ray et al.
patent: 5773696 (1998-06-01), Liang et al.
patent: 5783570 (1998-07-01), Yokota et al.
patent: 5786325 (1998-07-01), Borromeo et al.
patent: 5801172 (1998-09-01), Clapp-Shapiro et al.
patent: 5807854 (1998-09-01), Bartroli et al.
patent: 5814634 (1998-09-01), Nishino et al.
patent: 5824698 (1998-10-01), Hasler et al.
patent: 5824874 (1998-10-01), Ulbrich et al.
patent: 5830855 (1998-11-01), Takemoto
patent: 5830889 (1998-11-01), Iwata et al.
patent: 5837253 (1998-11-01), Cohen
patent: 5837726 (1998-11-01), Liu et al.
patent: 5849956 (1998-12-01), Koga et al.
patent: 5854213 (1998-12-01), Bouffard
patent: 5854280 (1998-12-01), Gomez et al.
patent: 5856347 (1999-01-01), Hashiguchi et al.
patent: 5859032 (1999-01-01), Nishino et al.
patent: 5861430 (1999-01-01), Markonius
patent: 5863773 (1999-01-01), Gunawardana et al.
patent: 5866549 (1999-02-01), Or et al.
patent: 5872249 (1999-02-01), Park et al.
patent: 5876738 (1999-03-01), Ohno et al.
patent: 5888526 (1999-03-01), Tsubai et al.
patent: 5888941 (1999-03-01), Bartroli et al.
patent: 5891890 (1999-04-01), Nishino et al.
patent: 5908862 (1999-06-01), Wai Lee et al.
patent: 5910498 (1999-06-01), Yazaki et al.
patent: 5917084 (1999-06-01), Jiang
patent: 5919438 (1999-07-01), Saint-Leger
patent: 5919925 (1999-07-01), Burton et al.
patent: 6005083 (1999-12-01), Kasina
patent: 6177551 (2001-01-01), Kasina
patent: 6187910 (2001-02-01), Kasina
patent: 6241961 (2001-06-01), Benes et al.
patent: 6528627 (2003-03-01), Kasina
patent: 6767531 (2004-07-01), Fritzberg et al.
patent: 2002/0176818 (2002-11-01), Fritzberg et al.
patent: 2003/0118508 (2003-06-01), Simon et al.
patent: 2003/0158393 (2003-08-01), Kasina
patent: 2004/0096393 (2004-05-01), Fritzberg et al.
patent: 2005/0063905 (2005-03-01), Fritzberg et al.
patent: 2005/0238578 (2005-10-01), Fritzberg et al.
patent: 1078731 (1980-06-01), None
patent: 0 164 843 (1985-12-01), None
patent: 0 210 043 (1987-01-01), None
patent: 0 232 751 (1987-08-01), None
patent: 0 255 471 (1988-02-01), None
patent: 0 258 616 (1988-03-01), None
patent: 0 287 465 (1988-10-01), None
patent: 0 374 501 (1990-06-01), None
patent: 0 382 582 (1990-08-01), None
patent: 0 408 701 (1991-01-01), None
patent: 0 411 941 (1991-02-01), None
patent: 0 455 380 (1991-11-01), None
patent: 0 698 029 (1996-02-01), None
patent: 0 972 528 (2000-01-01), None
patent: 2 230 374 (1974-12-01), None
patent: WO 84/03698 (1984-09-01), None
patent: WO 90/06776 (1990-06-01), None
patent: WO 91/16075 (1991-10-01), None
patent: WO 93/25240 (1993-12-01), None
patent: WO 94/26753 (1994-11-01), None
patent: WO 95/10940 (1995-04-01), None
patent: WO 98/43678 (1998-10-01), None
patent: WO 01/91806 (2001-12-01), None
patent: WO 02/062398 (2002-08-01), None
“Abstract Book, Annual Congress of the EANM”,European Journal of Nuclear Medicine and Molecular Imaging, 31, Helsinki, 2004, including abstracts P908, P925-P936, and P946-P952 (2004).
“Manufacture of Triethylene Tetramine”,Research Disclosure, 315, No. 31591, 595 (1990).
Goldman, “Good Drug, Bad Luck: Business, Regulatory Issues Can Create Obstacles for Drug Development”,Journal of the National Cancer Institute, 96, 1573-1574 (2004).
Kyle et al., “Multiple Myeloma”,The New England Journal of Medicine, 351, 1860-1873 (2004).
Cleynhens et al., “99mTc-EC-AMDP, a Bone Agent with Rapid Clearance from Soft Tissue”,Technetium, Rhenium and Other Metals in Chemistry and Nuclear Medicine, 5, 605-609 (1999).
Cohen et al., “Bisphosphonates and Tetracycline: Experimental Models for Their Evaluation in Calcium-Related Disorders”,Pharmaceutical Research, 15, 606-613 (1998).
Eisenhut et al., “The Influence of Substituents in99mTc-Benzylidenediphosphonate Complexes on their Organ Distribution in Rats”,Nuklearmedizin, 23, 119-122 (1984).
Fujisaki et al., “Physicochemical Characterization of Bisphosphonic Carboxyfluorescein for Osteotropic Drug Delivery”,J Pharm Pharmacol., 48, 798-800 (1996).
Jarvis et al., “Characterization of the Bisphosphonate Recognition Site on Hydroxyapatite Using Radioligand Binding Techniques with [14C]Citric Acid”,Calcif Tissue Int., 52, 372-377 (1993).
Larsen et al., “Preliminary Evaluation of a New Radiolabelled Bisphosphonate”,Journal of Labelled Compounds and Radiopharmaceuticals, XLI, 823-830 (1998).
Anderson et al., “High-Dose Samarium-153 Ethylene Diamine Tetramethylene Phosphonate: Low Toxicity of Skeletal Irradiation in Patients with Osteosarcoma and Bone Metastases”,Journal of Clinical Oncology, 20, 189-196 (2002).
Bensinger et al., “166Ho-DOTMP and High-Dose Melphalan before Autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple Myeloma”, Abstract P287; IXth International Workshop on Multiple Myeloma (2003).
Bensinger et al., “Skeletal Targeted Rad
Jones Dameron L.
NeoRx Corporation
Schwegman Lundberg Woessner & Kluth P.A.
LandOfFree
Skeletal-targeted radiation to treat bone-associated... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Skeletal-targeted radiation to treat bone-associated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Skeletal-targeted radiation to treat bone-associated... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3696825